[go: up one dir, main page]

CL2019003670A1 - Composición que comprende manosa oligosacárido y proceso para realizarla y uso de esta. - Google Patents

Composición que comprende manosa oligosacárido y proceso para realizarla y uso de esta.

Info

Publication number
CL2019003670A1
CL2019003670A1 CL2019003670A CL2019003670A CL2019003670A1 CL 2019003670 A1 CL2019003670 A1 CL 2019003670A1 CL 2019003670 A CL2019003670 A CL 2019003670A CL 2019003670 A CL2019003670 A CL 2019003670A CL 2019003670 A1 CL2019003670 A1 CL 2019003670A1
Authority
CL
Chile
Prior art keywords
composition
make
mannose oligosaccharide
mannose
oligosaccharide
Prior art date
Application number
CL2019003670A
Other languages
English (en)
Inventor
Bruno Frédéric STENGEL
Christof Franz Küsters
Original Assignee
Cargill Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cargill Inc filed Critical Cargill Inc
Publication of CL2019003670A1 publication Critical patent/CL2019003670A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pediatric Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A UNA COMPOSICIÓN QUE COMPRENDE MANOSA OLIGOSACÁRIDO Y UN PROCESO PARA REALIZARLA. LA PRESENTE INVENCIÓN SE REFIERE, ADEMÁS, A UNA COMPOSICIÓN QUE COMPRENDE MANOSA OLIGOSACÁRIDO PARA USO EN EL TRATAMIENTO DE HUMANOS O ANIMALES.
CL2019003670A 2017-06-14 2019-12-13 Composición que comprende manosa oligosacárido y proceso para realizarla y uso de esta. CL2019003670A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17175981 2017-06-14

Publications (1)

Publication Number Publication Date
CL2019003670A1 true CL2019003670A1 (es) 2020-05-15

Family

ID=59061903

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019003670A CL2019003670A1 (es) 2017-06-14 2019-12-13 Composición que comprende manosa oligosacárido y proceso para realizarla y uso de esta.

Country Status (13)

Country Link
US (2) US11771124B2 (es)
EP (1) EP3638254A1 (es)
JP (2) JP2020527334A (es)
KR (1) KR102663532B1 (es)
CN (1) CN110753550A (es)
AU (2) AU2018284983B2 (es)
BR (1) BR112019026661A2 (es)
CA (1) CA3066727A1 (es)
CL (1) CL2019003670A1 (es)
EC (1) ECSP19090645A (es)
MX (1) MX384068B (es)
PH (1) PH12019550265B1 (es)
WO (1) WO2018232078A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021183558A1 (en) 2020-03-09 2021-09-16 Cargill, Incorporated Sweetener composition
WO2021183561A1 (en) 2020-03-09 2021-09-16 Cargill, Incorporated Sweetener composition
BR112022017996A2 (pt) * 2020-03-13 2022-10-25 Cargill Inc Composição purificada, uso de uma composição, processo para a fabricação de uma composição, e, produto cosmético ou para cuidados pessoais
WO2021243151A1 (en) 2020-05-29 2021-12-02 Cargill, Incorporated Use of mannose oligosaccharide compositions for feeding crustaceans
CN115720490A (zh) * 2020-05-29 2023-02-28 嘉吉公司 包含葡萄糖寡糖的组合物及其制备方法和用途
US20230225350A1 (en) 2020-05-29 2023-07-20 Cargill, Incorporated Fat-based compositions
WO2022245567A1 (en) 2021-05-20 2022-11-24 Smile Makers, Llc Oral hygiene compositions and methods of use
WO2024242807A1 (en) 2023-05-25 2024-11-28 Cargill, Incorporated Co-dried fiber product comprising a core of insoluble fiber and an at least partial coating of soluble fiber

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0717685B2 (ja) * 1986-09-01 1995-03-01 台糖株式会社 縮合糖の製造方法
JPH089989A (ja) 1994-07-04 1996-01-16 Meiji Milk Prod Co Ltd β−マンノシルオリゴ糖の製造方法
US6559302B1 (en) 1997-03-19 2003-05-06 Pankaj Shashikant Shah Polymerization of mono-and disaccharides using low levels of mineral acids
JP2002262827A (ja) * 2001-03-13 2002-09-17 Ajinomoto General Foods Inc マンノオリゴ糖を含有する血清脂質改善組成物
JP3920073B2 (ja) 2001-10-17 2007-05-30 昭和産業株式会社 新規α−１，２−マンノシダーゼ及び該酵素を用いたα−マンノシル糖化合物の製造法
JP2003231694A (ja) 2002-02-06 2003-08-19 Hokkaido Electric Power Co Inc:The 糖類重合体及びグリコシド類の製造方法
JP4259169B2 (ja) * 2003-04-16 2009-04-30 昭和産業株式会社 新規α−１，２−マンノシダーゼおよびその遺伝子、ならびに該酵素を用いたα−マンノシル糖化合物の製造方法
JP4488852B2 (ja) 2004-09-17 2010-06-23 味の素ゼネラルフーヅ株式会社 体内脂肪低減作用を有する組成物
US8729051B2 (en) 2006-05-30 2014-05-20 Nutrition Sciences N.V./S.A. Tri- and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens
ES2720331T3 (es) * 2010-01-28 2019-07-19 Cargill Inc Microprocesamiento para preparar un policondensado
EP2433970A1 (en) * 2010-09-28 2012-03-28 Cargill, Incorporated Microprocessing for preparing a polycondensate
CN106473159A (zh) * 2010-11-05 2017-03-08 波士顿治疗公司 纯化可溶性甘露聚糖的制备方法以及纯化甘露聚糖组合物
JP4966429B1 (ja) * 2011-01-07 2012-07-04 日本食品化工株式会社 糖縮合物並びにその製造方法および用途
JP2012158526A (ja) * 2011-01-31 2012-08-23 Niigata Institute Of Science & Technology Niigata Univ Of Pharmacy & Applied Life Sciences マンノオリゴ糖の製造法
JP5671594B2 (ja) * 2012-11-28 2015-02-18 日本食品化工株式会社 糖縮合物の製造法
CA2945793C (en) 2014-04-14 2021-01-12 Biothera, Inc. Yeast cell wall enriched in mannan oligosaccharide protein
HK1246800A1 (zh) * 2015-01-26 2018-09-14 Cadena Bio, Inc. 用於营养组合物的寡糖组合物和其制造方法
HK1246604A1 (zh) 2015-01-26 2018-09-14 Cadena Bio, Inc. 用作食品成分的寡糖组合物和其制造方法
JP6692629B2 (ja) 2015-11-20 2020-05-13 国立大学法人静岡大学 ムチン分泌促進剤及びその利用
US20170173066A1 (en) 2015-12-22 2017-06-22 Purina Animal Nutrition Llc Method of feeding animals glucomannoprotein products

Also Published As

Publication number Publication date
WO2018232078A1 (en) 2018-12-20
MX2019015124A (es) 2020-02-17
JP7607063B2 (ja) 2024-12-26
MX384068B (es) 2025-03-14
CN110753550A (zh) 2020-02-04
RU2019144988A (ru) 2021-06-30
BR112019026661A2 (pt) 2020-06-23
KR20200019170A (ko) 2020-02-21
JP2020527334A (ja) 2020-09-10
KR102663532B1 (ko) 2024-05-08
PH12019550265A1 (en) 2021-01-11
RU2019144988A3 (es) 2021-10-08
ECSP19090645A (es) 2020-01-31
PH12019550265B1 (en) 2024-03-01
EP3638254A1 (en) 2020-04-22
AU2024227393A1 (en) 2024-11-07
AU2018284983A1 (en) 2020-01-30
US20230413885A1 (en) 2023-12-28
JP2023071803A (ja) 2023-05-23
CA3066727A1 (en) 2018-12-20
US20200297019A1 (en) 2020-09-24
US11771124B2 (en) 2023-10-03
AU2018284983B2 (en) 2024-07-25

Similar Documents

Publication Publication Date Title
CL2019003670A1 (es) Composición que comprende manosa oligosacárido y proceso para realizarla y uso de esta.
CL2019000979A1 (es) Composiciones y anticuerpos anti-lag-3.
CR20190350A (es) INHIBIDORES DE TGFß1 ISOFORMA-ESPECÍFICOS CONTEXTO-PERMISIVOS Y USO DE LOS MISMOS
CL2019003636A1 (es) Polinucleótidos de aadc para el tratamiento de la enfermedad de parkinson.
CO2019012353A2 (es) Formulaciones de anticuerpos anti-lag3 y coformulaciones de anticuerpos anti-lag3 y anticuerpos anti-pd-1
PE20180243A1 (es) Composiciones que comprenden cepas bacterianas
SV2018005610A (es) Derivados de oxopiridina sustituidos
MX2018005315A (es) Composiciones y metodos para el tratamiento del cancer.
PE20180266A1 (es) Composiciones que comprenden cepas bacterianas
MX2018004515A (es) Agentes de anticuerpo especificos para cd19 humano y usos de los mismos.
MX379270B (es) Composiciones que comprenden cepas bacterianas.
CO2017005784A2 (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades
MX383164B (es) Composicion que contiene arn para tratamiento de enfermedades tumorales.
CL2016002971A1 (es) Combinación.
MX395231B (es) Compuestos eficaces en el tratamiento de la hepatotoxicidad y enfermedades de hígado graso, y uso de los mismos.
CO2017007121A2 (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades
AR096478A1 (es) Composiciones para el tratamiento de superficie que comprenden tintes fotocromáticos
MX2016009625A (es) Proteinas quimericas tipo fosfatasa alcalina.
CL2019001996A1 (es) Usos terapéuticos de un polvo de insectos.
CL2016003074A1 (es) Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer.
MX2018012285A (es) Metodos de tratamiento para enfermedades colestasicas y fibroticas.
CO2017011778A2 (es) Un inhibidor de la actividad del csf-1r y composiciones farmaceuticas que lo comprenden
MX2017007000A (es) Composiciones que comprenden acido 15-hidroxieicosapentaenoico (15-hepe) y metodos para tratar o prevenir la fibrosis usando las mismas.
MX2018005987A (es) Compuestos heterociclicos para el tratamiento de enfermedades.
MX392976B (es) Composiciones que comprenden cepas bacterianas.